The Rosen Law Firm has announced a class action lawsuit against Capricor Therapeutics, Inc., targeting investors who purchased securities between O...
Significant stakeholders in Skye Bioscience, including Director Andrew Schwab and 5AM Partners VII, LLC, have sold 231,405 shares each, valued at $...
Novo Nordisk has emerged as a leader in the oral obesity treatment market, following disappointing efficacy results from competitors Eli Lilly and ...
Recent trials for oral obesity treatments from Eli Lilly and Viking Therapeutics have yielded underwhelming results, with Novo Nordisk emerging as ...
The obesity treatment market is witnessing intense competition among pharmaceutical companies, with numerous firms striving to capture market share...
Sarepta Therapeutics, Inc. is facing a class action lawsuit following reports of severe adverse effects associated with its gene therapy, ELEVIDYS....
The Gross Law Firm has announced a class action lawsuit against Capricor Therapeutics, Inc. following the FDA's rejection of its Biologics License ...
Telehealth company Ro has launched a new campaign featuring tennis champion Serena Williams, focusing on her personal experience with GLP-1 injecti...
AtriCure, Inc., a leader in surgical treatments for atrial fibrillation (Afib) and related conditions, has announced its participation in the 2025 ...
Recent insider trading activity at Skye Bioscience has seen Director Andrew Schwab and significant shareholder 5AM Partners VII, LLC each selling 2...